Selway Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
- Revenue Growth 164.01%
- Profit Growth 180.76%
- Ebitda 21.30%
- Net Worth 207.43%
- Total Assets 105.37%
About Selway Lifesciences
Selway Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2018 (Six years and ten months 9 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 Cr.
Ritu Jain, Neha Chaturvedi, Chirag Agrawal, and One other member serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UP2018PTC103347
- Company No.
103347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Selway Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritu Jain  | Director | 18-Apr-2018 | Current |
| Neha Chaturvedi | Director | 18-Apr-2018 | Current |
| Chirag Agrawal | Director | 08-Mar-2022 | Current |
| Jai Pandey | Director | 08-Mar-2022 | Current |
Financial Performance of Selway Lifesciences.
Selway Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 164.01% increase. The company also saw a substantial improvement in profitability, with a 180.76% increase in profit. The company's net worth Soared by an impressive increase of 207.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Selway Lifesciences?
Unlock access to Selway Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Selway Labs Private LimitedChirag Agrawal and Jai Pandey are mutual person
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Hdfc Bank Limited | ₹4.00 Cr | Open |
How Many Employees Work at Selway Lifesciences?
Unlock and access historical data on people associated with Selway Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Selway Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Selway Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
